IFP Advisors’s Tectonic Therapeutic TECX Stock Holding History

IFP Advisors’s Portfolio TECX Stock Details TECX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-292	Closed	-$5.39K	–	3378
2023 Q3	$5.39K	Buy	+292	New	+$5.16K	﹤0.01%	2474

Other funds holding TECX

AVLSA

Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return

BCM

BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return

Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ACM

Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

VAM

Vazirani Asset Management New York $43.4M AUM 84.05% 1-Year Est. Return

IFP Advisors's TECX Position: Q4 2023 in Review

IFP Advisors sold out of Tectonic Therapeutic (TECX) in Q4 2023, closing a stake of 292 shares — an estimated $5.39K sold.

IFP Advisors first reported a position in TECX in Q3 2023 and held it in 1 quarter. The position peaked at $5.39K in Q3 2023. 45 funds tracked by Wall St. Rank hold TECX as of Q4 2023.

IFP Advisors reported no remaining Tectonic Therapeutic position as of Q4 2023 after selling out during the quarter.
IFP Advisors sold 292 Tectonic Therapeutic shares in Q4 2023, an estimated $5.39K.
IFP Advisors first reported a position in Tectonic Therapeutic in Q3 2023 and held it in 1 quarter.
IFP Advisors's Tectonic Therapeutic position peaked at $5.39K in Q3 2023.
45 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q4 2023.

Based on IFP Advisors's 13F filing for Q4 2023, filed 9 Jan 2024.